AAA
DTIL icon

Affinity Asset Advisors’s Precision BioSciences DTIL Stock Holding History

Affinity Asset Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.08M Buy
646,576
+48,630
+8% +$342K 0.23% 79
2026
Q1 		$3.29M Buy
+597,946
New +$2.76M 0.17% 85

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Affinity Asset Advisors's DTIL Position: Q2 2026 in Review

Affinity Asset Advisors increased its Precision BioSciences (DTIL) stake by 8.1% in Q2 2026, buying an estimated $342K and bringing the position to 646,576 shares worth $5.08M. The position accounts for 0.23% of the portfolio, ranked #79.

Affinity Asset Advisors first reported a position in DTIL in Q1 2026 and has held it in 2 quarters since. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Affinity Asset Advisors held 646,576 shares of Precision BioSciences worth $5.08M as of Q2 2026.
  • Affinity Asset Advisors bought 48,630 Precision BioSciences shares in Q2 2026, an estimated $342K.
  • Precision BioSciences made up 0.23% of Affinity Asset Advisors's portfolio in Q2 2026, its #79 holding.
  • Affinity Asset Advisors first reported a position in Precision BioSciences in Q1 2026 and has held it in 2 quarters since.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Affinity Asset Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.